Background: Hidradenitis suppurativa (HS) is a chronic, inflammatory, recurrent skin disease of the pilosebaceous unit characterized by protean manifestations. Several studies have found an increased incidence and earlier presentation of this disease in patients carrying trisomy 21. Patients with Down syndrome (DS) have a higher risk of developing a wide range of cutaneous manifestations, including HS and chronic folliculitis. Recently, disseminate recurrent folliculitis (DRF) has been reported as an atypical monosymptomatic feature of HS at its onset.
where a more than 5-fold higher risk of developing HS has been reported [8] .
The primary endpoint of this study was to investigate the prevalence of HS and DRF of any body area in patients with DS. The second endpoint was to evaluate the clinical features (including anatomical distribution, disease severity) of these 2 conditions in the affected population and to verify whether there was a statistically significant correlation.
Materials and Methods
Medical records were used to perform a 2-year single-center retrospective study on 131 patients with DS followed at the Down Syndrome Regional Center and referred to the Derma- Iconographic and dermoscopic data were reviewed to detect skin signs of DRF and HS in order to identify 4 different cohorts in the studied population: patients with cooccurrence of hidradenitis and folliculitis (HS+F+), those presenting only DRF (HS-F+), those with HS alone (HS+F-), and those with neither of the 2 conditions (HS-F-).
DRF was defined as a noninfectious inflammatory reaction of hair follicles presenting with multiple papules, pustules, papulopustules, or follicular papules with keratotic plug and perifollicular scarring affecting any body area and characterized by a chronic relapsing course lasting more than 6 months.
The spectrum of KP was excluded by taking into account the following factors: morphological features, anatomical distribution, and dermoscopic pattern [9] . Spiny keratotic Introduction Down syndrome (DS) is the most common chromosomal disorder and is characterized by congenital heart defects, endocrinological disorders, neurological abnormalities, immunological disturbances, and a wide range of cutaneous manifestations. The cutaneous diseases associated with DS include alopecia areata, vitiligo, atopic dermatitis, psoriasis, elastosis perforans serpiginosa, syringomas, xerosis with palmoplantar hyperkeratosis, and folliculitis [1] ; folliculitis was found to be the most common dermatological manifestation in patients with DS [2] .
Folliculitis is an inflammatory reaction of hair follicles with possible involvement of the follicular opening and the perifollicular area. Its classification is based on histopathological or laboratory features, infectious agents, topographic distribution, recognized mechanism, disease duration, and localization within the pilosebaceous compartments [3] .
Chronic, relapsing folliculitis with secondary anetoderma has been widely reported in patients affected by DS [4] . The recalcitrant course of the folliculitis, in synergy with the congenital malformation of elastic fibers in patients with DS, can lead to irreversible elastolysis, which is responsible for the anetodermal scarring [2] . The exact etiology is still a matter of discussion. Some authors have postulated the role of infective triggers such as Staphylococcus aureus or Malassezia [5] , while others have suggested a link between chronic folliculitis and keratosis pilaris (KP), as the follicular expressions of a generalized xerotic condition [6] . Patients with DS are probably more susceptible to cutaneous infections including bacterial folliculitis, furuncles, abscesses, and secondary impetigo [1] .
Long-term disseminate folliculitis of noninfectious etiology is difficult to frame in dermatology [7] . Several skin disorders such as atopic dermatitis, psoriasis, pityriasis rubra pilaris, and hidradenitis suppurativa (HS) often show follicular lesions, variably associated with other typical skin signs.
Disseminate recurrent folliculitis (DRF) has been proposed as one of the presenting features of an atypical monosymptomatic form of HS. A population-based cross-sectional analysis found a 2.1% prevalence of HS in patients with DS vs a 0.3% in nonaffected controls. This association was stronger in the DS population aged between 18 and 29 years, proved to be statistically significant in both groups (P < 0.05). In the DS cohort the mean age of symptoms onset was 15.67 (SD: 2.29) years for HS and 13.11 (SD: 4.93) years for DRF. Buttocks were the most frequently affected body area for DRF followed by the inguinocrural area, while in HS buttocks were less frequently involved than groins and upper thighs.
Conclusions:
Because of the later onset of HS, patients with DRF at an early age should be monitored for the possible onset of HS in the apocrine-bearing areas.
Moreover, patients presenting recalcitrant folliculitis with positive cutaneous swab for bacteria or fungi were not included.
HS was identified according to the diagnostic criteria provided by the European consensus guidelines for the treatment of HS: history of recurrent suppurating lesions (including inflammatory nodules, sinus tracts, abscess, and subsequent scarring) in the apocrine gland-bearing areas, occurring at least twice in a 6-month period [10] .
Past medical and family history of dermatological conditions was recorded in patients affected by HS to establish disease duration and age at HS symptom onset.
For each patient the following data were collected: age, sex, anatomical pictures of affected body segments, elementary lesions and their anatomical distributions, and disease severity of HS according to Hurley's classification [11] .
Statistical Analysis
Associations between HS and DRF, expressed as dichotomous variables, were assessed using chi-square test calculated on contingency tables. Proportions were estimated with 95% exact confidence interval based on the binomial distribution.
The risk ratio was estimated by the odds ratio together with 95% approximate confidence interval. Statistical tests were 2-sided and P < 0.05 was considered statistically significant.
All analyses were performed using SPSS for Mac v22.0 (IBM Corp, Armonk, NY). Age at DRF onset could be established in 18/32 HS-F+ and in 7/7 HS+F+ patients. The mean age at onset of symptoms was 15.67 (SD: 2.29) years for HS and 13.11 (SD: 4.93) years for DRF. Disease severity of HS was assessed using Hurley's classification score [11] . In the HS+F+ group the disease severity was classified as stage I in 2/7 patients (28.6%) and stage II in 5/7 patients (71.4%). The 2 patients belonging to the HS+F-cohort were staged with Hurley severity score I. Medical history was accurately recorded in all cases: no patient had undergone HS-related surgery or had a positive family history for HS (Table 1) Overall data were partially lacking in important details, such as age at onset of symptoms and associated clinical pictures in some cases ( Table 1) .
Results

Patients With DS
The association between HS and DRF, assessed by chisquare test, was statistically significant both in DS and control groups (P value: 0.0039 and 0.00027, respectively). The 
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None of the patients had clinical evidence of any of the occlusion tetrad syndrome signs associated with HS (pilonidal cyst, dissecting cellulitis of the scalp, acne conglobata) [12] .
Discussion
In the general population, the prevalence of HS varies from 0.00033% [13] to 4% [14] . Cosmatos et al recently assessed
the HS prevalence at 0.053%, with a rate for women almost triple that of men [15] .
In our retrospective analysis the prevalence of HS reached 6.8% of the DS population, which is even higher than what is already reported in the literature on patients with DS [8, 16] .
Compared to the control group the prevalence was 13.6-and 20-fold higher for HS and DRF, respectively. It is also known that HS starts earlier in life in DS, with the highest incidence occurring in the group aged 18-29 compared with the general HS population [8, 16] . Many efforts have aimed to better investigate the pediatric onset of HS, and, to date, there are only 14 cases published in the literature [17] .
Palmer and Keefe investigated early HS in the general HS population, assessing a 2% prevalence below the age of 11 years [18] , whereas different data come from a more recent study, which found a prepubertal onset of HS in 7.7% of the studied HS cohort, by setting the cutoff point at 13.5
years [19] .
The prevalence of HS in our control group was 0.5%
(63/12,351), which is much higher than the supposed 1% prevalence under 18 years of age in a previously studied HS cohort [20] .
The median age at onset of HS symptoms in our DS A possible bias is the relatively low age of controls, due to the fact that all patients were recruited from the pediatric dermatology outpatient service.
The male-to-female ratio in our DS HS+ groups was 5:4, so a slightly higher male prevalence was detected. The male prevalence of HS in patients with DS is also confirmed by a wide cross-longitudinal study published in the literature [8] ;
this trend is reversed in the HS population not associated with DS, presenting a female prevalence (female-to-male ratio 2.8:1), with a peak in patients aged 30-39 years [22] .
In fact, in the HS+ control group a female-to-male ratio of 1 [24, 25] . Type VI collagen is an extracellular matrix molecule abundantly expressed in the dermis, which plays a key role in the processes of hair follicle cycling and wound healing, tissue repair through the regulation of the dermal matrix assembly, and fibroblastic motility [24, 26] . It has a heterotrimeric structure, consisting of 3 distinct polypeptide chains: α1, α2, and α3. The increase in collagen VI is due to an upregulation of the transcription of the COL6A1 and COL6A2 genes located in the chromosome 21, respectively, encoding for the α1 and α2 chains, due to a gene dosage effect [24] . Two diseases associated with impairment of type VI collagen are Ullrich congenital muscular dystrophy and Bethlem myopathy, which are also characterized by abnormal skin findings, including follicular hyperkeratosis, hypertrophic and keloid scarring, and cutaneous xerosis [26] .
It is possible to hypothesize that a mechanical stress exerted on compromised follicular units can activate abnormal extracellular remodeling, leading to scarring evolution. This might explain, in the HS+F+ cohort, the progression of DRF into tract formation and cicatrization at intertriginous sites, bypassing the HS severity stage I.
As suggested by Revuz, DRF is a gray area in the field of dermatology, as it cannot be associated univocally with a specific disease or etiology [7] . Even though DRF belongs to the clinical spectrum of HS, it is not mentioned among the diagnostic criteria. As a consequence, a diagnosis of HS cannot be postulated on the basis of DRF presenting as painful papulopustules with a lack of closed comedones or microcysts. Assuming that DRF may represent a mode of presentation of HS [7] , in some patients belonging to the HS-F+ group, DRF possibly represents the initial pre-Hurley stage I of HS. This hypothesis could represent the key to explain not only the statistical correlation between HS and DRF, but also the age mismatch at symptom onset between the HS+F+ and HS+F-cohorts.
Disease location of DRF in the HS+F+ DS group favored the inguinocrural area, which was involved in all patients, followed by the buttocks and abdomen detected in 6/7 cases.
On the other hand, the buttocks represent the most frequent Another possible predisposing factor in both HS and DRF is obesity, which has also been frequently associated with DS [28] . Weight gain leading to obesity usually occurs after puberty, causing an increase of mechanical friction in the areas of skin-to-skin contact. Moreover, it causes a proinflammatory state through increased levels of resistin and chemerin, which are responsible for insulin resistance and upregulation of the follicular androgen receptor, leading to follicular occlusion [29] .
In addition, the intrinsic immunodeficiency of DS [30] facilitates microbial growth and proliferation in the superficial segments of hair follicles and in the perifollicular space.
As a consequence, bacterial infections may contribute to HS progression leading to disease extension and scarring evolution [31] . and damage-associated molecular patterns activate the autoinflammatory and inflammasome pathway [33] .
The higher prevalence of HS in patients with DS can be explained by the impaired Notch-MKP signaling: in trisomy21, the increased level of amyloid precursor protein (APP) reduces Notch signaling, acting as a competitive substrate of γ-secretase [34] , resulting in the persistence of autoinflammation [35] . Furthermore, APP and its cleavage product (secretory N-terminal ectodomain of APP) promote keratinocyte migration, adhesion, and proliferation [36] . This results in the plugging and dilation of hair follicles, which leads to follicular hyperkeratosis, hyperplasia of the follicular epithelium, and rupture of hair follicles with consequent perifolliculitis and cyst formation [36] .
This study has several limitations due to the lack of validation criteria for the DRF diagnosis, the lack of a longterm prospective study regarding the HS-DRF association, and the lack of ethnicity variability, since the great majority of the enrolled population consists of Caucasians. A higher incidence of HS has, in fact, been reported in the African American ethnic group in 2 studies [37, 38] . Garg et al demonstrated a 2.5-fold higher incidence of HS in this population [37] , while Vlassova et al identified African American women as being exposed to the highest risk of developing HS [38] .
To sum up, trisomy 21 carries genetic alterations that are responsible for hair follicle imbalances and consequent occlusion. The follicular plugging acts in synergy with other promoting factors such as obesity, mechanical stress, pubertal increase in circulating androgens, and insulin resistance.
Added to this is the promoting role of the alteration of the collagen component, which may be responsible for the evolution toward profibrotic phenotype.
Conclusions
Both DRF and HS are commonly detected in patients carrying trisomy 21 and might be considered 2 associated features of the same syndromic condition [39] . On the other hand, there are no studies concerning the prevalence of DRF in the general pediatric population, since the validity of DRF as a separate entity is still debated. DRF is also thought to be associated with a variant of KP, which also occurs under the follicular occlusion disease spectrum [9] .
In our clinical practice, we identify pediatric patients at risk of developing HS by taking into account several parameters, which are reported in Table 2 ; positivity for 2 or more parameters leads us to follow up patients at risk every 6 months, to identify early signs of HS. Although this is not a validated tool, it might be useful to recognize patients eligible for HS screening.
To determine more accurately whether DRF is a separate entity or an early pre-Hurley stage I of HS, it will be useful to follow DRF lesions longitudinally through photographic and ultrasound evaluation. The latter has become a very promising, widely available imaging modality for HS, able to detect subclinical changes occurring in early stages, as well as the initial hair follicle dilation, increased thinning, or abnormal echogenicity of the dermal layer [40] . 
Recommendation Criteria for HS Screening in Pediatric Patients
Familial background: Family history positive for HS in at least 1 first-degree relative.
Genetics: Syndromes with known genetic abnormalities (Bazex-Dupré-Christol syndrome, Dowling-Degos disease, DS, keratitis-ichthyosis-deafness syndrome), Dent disease 2.
Ethnicity: Descent from African and Hispanic populations.
Clinical findings: History of disseminate recurring folliculitis lasting more than 6 months, involving at least 2 body areas (either mono-or bilaterally) not attributable to known etiological factors.
Endocrinological abnormalities: Clinical and laboratory findings of insulin resistance, peripheral hyperandrogenism, polycystic ovarian syndrome.
Follicular occlusion signs:
Clinical evidence of at least 1 of the occlusion tetrad syndrome signs associated with HS (pilonidal cyst, dissecting cellulitis of the scalp, acne conglobata).
Smoking:
Smoking habits or smoke exposure in indoor environments (secondhand smoke).
Ultrasound: Detection of any of the sonographic features suggestive for subclinical follicular abnormalities, including widening of the hair follicles, thickening or abnormal echogenicity of the dermis, and dermal pseudocystic nodules.
